Faculty Opinions recommendation of Neurally adjusted ventilatory assist (NAVA) improves patient-ventilator interaction during non-invasive ventilation delivered by face mask.

Author(s):  
Jennifer Beck
2012 ◽  
Vol 38 (10) ◽  
pp. 1624-1631 ◽  
Author(s):  
Lise Piquilloud ◽  
Didier Tassaux ◽  
Emilie Bialais ◽  
Bernard Lambermont ◽  
Thierry Sottiaux ◽  
...  

JMS SKIMS ◽  
2020 ◽  
Vol 23 (3) ◽  
Author(s):  
Tajamul Hussain Shah ◽  
Suhail Mantoo ◽  
Rafi Ahmad Jan

High Flow Nasal Cannula Oxygenation The current pandemic of COVID-19 caused by novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) tested the healthcare infrastructure throughout the globe at all possible levels. Early reports suggest about 20% of patients infected with SARS-CoV-2 require hospitalization and 5-8% require admission to intensive care unit (ICU) due to severe disease.Supplementation of oxygen provided by various conventional oxygen therapy (COT) devices (like nasal prongs, face mask, venture mask or non-rebreather mask) may not be sufficient in cases of worsening respiratory failure. One form of escalating respiratory support in such patients is a high flow nasal oxygenation device. High flow nasal cannula oxygenation (HFNC) is a form of non invasive respiratory support. It acts as a bridge between low flow devices and non invasive ventilation and may reduce the need for intubation.


Author(s):  
Cristina Puricelli ◽  
Eleonora Volpato ◽  
Salvatore Sciurello ◽  
Antonello Nicolini ◽  
Paolo Banfi

he standard treatment for patients with neuromuscular respiratory failure is non-invasive ventilation (NIV) as non-invasive ventilation support-setting (NVS). NVS is administered through a nasal or face mask and/or mouthpiece with the potential to cause nasal ulcers, discomfort, and/or aesthetic issues, resulting in poor compliance. We reported the observation of a 45-year-old woman with limb-girdle muscular dystrophy (LGMD), secondary to Dysferlin deficiency, who was on NVS since 2017 for nocturnal hypoventilation. In 2018, despite nocturnal ventilation, due to weight gain and daytime hypoventilation, a nasal mask was introduced. We initiated daytime intermittent abdominal pressure ventilation (IAPV) to mitigate cosmetic problems, improving in pO2 and decreasing in pCO2 versus baseline (52>84 mmHg, 46>33 mmHg respectively) at 6 (85 mmHg, 42 mmHg) and 18 months (93 mmHg, 38 mmHg), respectively. IAPV was effective, safe, and well-tolerated in our patients who did not tolerate standard daytime NVS with the known interface.


2002 ◽  
Vol 28 (3) ◽  
pp. 278-284 ◽  
Author(s):  
Cesare Gregoretti ◽  
Marco Confalonieri ◽  
Paolo Navalesi ◽  
Vincenzo Squadrone ◽  
Pamela Frigerio ◽  
...  

Critical Care ◽  
2020 ◽  
Vol 24 (1) ◽  
Author(s):  
Kate C. Tatham ◽  
Matthew Ko ◽  
Lisa Palozzi ◽  
Stephen E. Lapinsky ◽  
Laurent J. Brochard ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document